Sign in to fuzzto save your conversations, follow your research and come back anytime.
Nestle
SectorFMCG
Nestle India Ltd. is a major player in the FMCG segment, primarily focused on the food business. The company manufactures and sells products across categories including milk products and nutrition, prepared dishes and cooking aids, powdered and liquid beverages, and confectionery. Nestle India operates 8 manufacturing facilities and 4 branch offices across India, with its head office in Gurgaon, Haryana. Key brands include Nescafe, Maggi, Milkybar, Kitkat, Bar-One, Milkmaid, and Nestea. The company has expanded its product range over the years, introducing items like Nestle Milk, Nestle Slim Milk, Nestle Fresh 'n' Natural Dahi, and Nestle Jeera Raita. Nestle India also operates in the pet food segment with brands like Purina Friskies and Purina Fancy Feast. The company has received various certifications for its factories, including ISO 14001 for environmental processes and OSHAS 18001 for Health and Safety.
In the news
FSSAI's Wake-Up Call for HUL and Nestlé India
FSSAI cracks down on FMCG giants Nestle India and HUL over misleading labels
5 Stocks to Buy Today: Nestle, Tech Mahindra, Wipro, 360 One, Yes Bank
Nestlé India's Q2 FY27: Strong Growth, Inflation Shadows
Sensex jumps 1,534 points to 3-week high; Q2 results today
Nestle India Q2 results: Profit jumps 36%, shares tank 9% on inflation fears
Q2 Results Today: 50 Companies Report FY27 Earnings
5 Blue-chip Stocks with High RoE and Strong Growth Plans
FSSAI Issues Notice to The Lalit Over 'Unsafe' Nestle Dairy Whitener
HDFC Bank Down 26% YTD Amid Governance Crisis, Q2 Results Due Oct 17
Nestle India's Infant Nutrition Crisis: FSSAI Enforcement Reshapes Market
FSSAI Files Legal Action Against Nestle India on Three Infant Products
Nestle Vows Legal Action as Russia Seizes Assets Under Putin Decree
Nestle India shares jump 2.5% on Nuvama's bullish outlook
FSSAI's Regulatory Crackdown: Compliance Costs and Strategic Shifts in India's FMCG Sector
Nestle India falls for fifth straight session at ₹1,398.8
Nestle sells $1B vitamins business to Yellow Wood Partners
HDFC Bank, Sterlite Tech lead midday stock moves amid market decline
Britannia's Sugar Squeeze: Margin Risks and Strategic Options
FSSAI Red-Label Proposal: 150+ Companies Face Action
Company insights, generated from the most recent coverage.
Resource Renal is the more severe of the two Oct-2026 notices: an approval gap questions the right to sell the product at all, whereas HUL's claim issue leaves the product saleable once wording is corrected. Remediation also sits outside Nestle's control — it depends on FSSAI's approval timeline, so revenue risk persists for months.
Medical nutrition sits largely in a JV with Dr Reddy's, so approval responsibility spans two partners and multiple portfolios. The Resource Renal notice puts that shared governance model under scrutiny.
Third FSSAI matter inside four months — Maggi in June 2026, infant formula in September 2026, Resource Renal in October 2026. The cadence itself is the signal: this is no longer isolated SKU error but a systemic compliance-oversight problem across the portfolio.